4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0001493152-22-002203
Options or other derivatives
- Chief Financial Officer acquired 744,429 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ward Carter Julian Chief Financial Officer | 2022-01-19 | Grant or award · Restricted Stock Units | +744,429 | 744,429 | D | ||
Loading xslF345X03/ownership.xml…